Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

<div>Flow diagram of patients included in this substudy. GP = general practitioner, LMWH = low molecular weight heparin, SVT = splanchnic vein thrombosis, and VKA = vitamin K antagonist.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study 

Figure 1 | Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study 